Misconceptions about influenza vaccination
- 10 years
“You only catch the flu once every 10 years.”
30 January 2015
New analysis of efficacy data confirms that timely administration of the antiviral influenza drug oseltamivir considerably reduces the impact of an influenza infection in adults. The study results have now been published in The Lancet. Click here for the full article.
Fifth ESWI Influenza Conference: proceedings
2 January 2015
All speakers who contributed to the Fifth ESWI Influenza Conference’s outstanding scientific programme are now invited to submit their research paper to the corresponding special issue of Vaccine. The Fifth ESWI Influenza Conference Special Issue of Vaccine will feature original research articles and review articles. It will be published online in May 2015.
The deadline for submissions is 28 February 2015. The submission website for this journal is located at: http://ees.elsevier.com/jvac
To ensure that all manuscripts are correctly identified, it is important to select “SI: 5th ESWI Influenza Conference” when you reach the “Article Type” step in the submission process.
ESWI Board of Directors: important changes
17 October 2014
On 13 September 2014, the Board members of the European Scientific Working group on Influenza have elected Gülsah Gabriel as the new Vice-President of the group. Dr. Gabriel joined the ESWI Board in 2009 after she had won the first edition of the ESWI Young Scientist Best Body of Work Award. Dr. Gabriel has become a core member of the organization, owing to her very valuable and enthusiastic contributions to the objective of ESWI: to reduce the impact of influenza in Europe. The appointment of Dr. Gabriel as a Vice-President is an important step in the evolution of the organization as it underlines the fact that a new generation of excellent scientific researchers is ready to continue the fight against influenza.
The ESWI Board members have also unanimously accepted the candidacy of Prof. Selim Badur as a new Director of ESWI. Prof. Badur is the director of the Virology Lab at the University of Istanbul and has been one of the founders of the Turkish network of influenza stakeholders, called Grip Platformu. While warmly welcoming Prof. Badur, the ESWI Board members also wish to thank Dr. Meral Ciblak - who decided to step down from the ESWI Board - for her tireless and successful efforts to create a network of influenza stakeholders in Turkey.